Nuvalent (NUVL) News Today $74.98 -2.16 (-2.80%) Closing price 03/25/2025 04:00 PM EasternExtended Trading$75.04 +0.05 (+0.07%) As of 03/25/2025 07:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Nuvalent to Present New Preclinical Data on ALK-Selective Inhibitor, Neladalkib, and ROS1-Selective Inhibitor, Zidesamtinib, at AACR Annual Meeting 2025March 25 at 5:24 PM | prnewswire.comSwiss National Bank Has $5.51 Million Holdings in Nuvalent, Inc. (NASDAQ:NUVL)Swiss National Bank lifted its position in shares of Nuvalent, Inc. (NASDAQ:NUVL - Free Report) by 21.8% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 70,400 shares of the company's stock after purchasing an additionMarch 24 at 3:34 AM | marketbeat.comInsider Selling: Nuvalent, Inc. (NASDAQ:NUVL) CEO Sells 27,000 Shares of StockNuvalent, Inc. (NASDAQ:NUVL - Get Free Report) CEO James Richard Porter sold 27,000 shares of Nuvalent stock in a transaction on Monday, March 17th. The stock was sold at an average price of $75.87, for a total transaction of $2,048,490.00. Following the transaction, the chief executive officer now owns 249,062 shares in the company, valued at $18,896,333.94. This represents a 9.78 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.March 21, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Cuts Stake in Nuvalent, Inc. (NASDAQ:NUVL)Connor Clark & Lunn Investment Management Ltd. decreased its holdings in Nuvalent, Inc. (NASDAQ:NUVL - Free Report) by 55.1% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 15,155 shares of the company's stock after selling 18,609 shareMarch 21, 2025 | marketbeat.comRaymond James Financial Inc. Acquires Shares of 133,964 Nuvalent, Inc. (NASDAQ:NUVL)Raymond James Financial Inc. bought a new position in Nuvalent, Inc. (NASDAQ:NUVL - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 133,964 shares of the company's stock, valued at approximately $10,487,000. RayMarch 21, 2025 | marketbeat.comNuvalent, Inc. (NASDAQ:NUVL) CEO Sells $2,048,490.00 in StockNuvalent, Inc. (NASDAQ:NUVL - Get Free Report) CEO James Richard Porter sold 27,000 shares of the business's stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $75.87, for a total value of $2,048,490.00. Following the completion of the sale, the chief executive officer now directly owns 249,062 shares of the company's stock, valued at $18,896,333.94. The trade was a 9.78 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.March 20, 2025 | marketbeat.comVictory Capital Management Inc. Cuts Stock Position in Nuvalent, Inc. (NASDAQ:NUVL)Victory Capital Management Inc. lowered its stake in Nuvalent, Inc. (NASDAQ:NUVL - Free Report) by 86.6% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 20,135 shares of the company's stock after selling 130,064 shares duringMarch 19, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Buys 7,742 Shares of Nuvalent, Inc. (NASDAQ:NUVL)Charles Schwab Investment Management Inc. grew its stake in shares of Nuvalent, Inc. (NASDAQ:NUVL - Free Report) by 2.5% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 323,569 shares of the company's stock after acquiring an additional 7,March 19, 2025 | marketbeat.comNuvalent (NASDAQ:NUVL) Stock Rating Upgraded by UBS GroupMarch 16, 2025 | americanbankingnews.comUBS Upgrades Nuvalent (NUVL)March 15, 2025 | msn.comNuvalent (NASDAQ:NUVL) Upgraded by UBS Group to Buy RatingUBS Group upgraded Nuvalent from a "neutral" rating to a "buy" rating and set a $100.00 price objective for the company in a research report on Friday.March 15, 2025 | marketbeat.comBank of New York Mellon Corp Increases Holdings in Nuvalent, Inc. (NASDAQ:NUVL)Bank of New York Mellon Corp grew its holdings in Nuvalent, Inc. (NASDAQ:NUVL - Free Report) by 3.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 116,062 shares of the company's stock after acquMarch 15, 2025 | marketbeat.comNuvalent upgraded to Buy from Neutral at UBSMarch 14, 2025 | markets.businessinsider.comEdgestream Partners L.P. Purchases 8,895 Shares of Nuvalent, Inc. (NASDAQ:NUVL)Edgestream Partners L.P. raised its position in shares of Nuvalent, Inc. (NASDAQ:NUVL - Free Report) by 314.4% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 11,724 shares of the company's stock after buying an additional 8,895 shares duringMarch 12, 2025 | marketbeat.com4,805 Shares in Nuvalent, Inc. (NASDAQ:NUVL) Purchased by Aigen Investment Management LPAigen Investment Management LP purchased a new position in shares of Nuvalent, Inc. (NASDAQ:NUVL - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 4,805 shares of the company'sMarch 8, 2025 | marketbeat.comNuvalent, Inc. (NASDAQ:NUVL) Shares Acquired by Candriam S.C.A.Candriam S.C.A. raised its holdings in shares of Nuvalent, Inc. (NASDAQ:NUVL - Free Report) by 15.6% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 368,095 shares of the company's stock after acquiring an additional 49,728March 7, 2025 | marketbeat.comNuvalent, Inc. (NASDAQ:NUVL) Receives Consensus Rating of "Moderate Buy" from AnalystsNuvalent, Inc. (NASDAQ:NUVL - Get Free Report) has earned an average rating of "Moderate Buy" from the thirteen research firms that are currently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendation, ten haMarch 7, 2025 | marketbeat.comHC Wainwright Issues Negative Outlook for Nuvalent EarningsNuvalent, Inc. (NASDAQ:NUVL - Free Report) - Research analysts at HC Wainwright dropped their Q1 2025 earnings per share (EPS) estimates for Nuvalent in a report issued on Monday, March 3rd. HC Wainwright analyst S. Ramakanth now anticipates that the company will post earnings of ($1.21) per sharMarch 6, 2025 | marketbeat.comNuvalent (NASDAQ:NUVL) Given Buy Rating at HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $110.00 target price on shares of Nuvalent in a research note on Monday.March 3, 2025 | marketbeat.comNuvalent (NASDAQ:NUVL) Posts Earnings ResultsNuvalent (NASDAQ:NUVL - Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($1.05) earnings per share for the quarter, missing analysts' consensus estimates of ($1.03) by ($0.02).February 28, 2025 | marketbeat.comStifel Nicolaus Keeps Their Buy Rating on Nuvalent (NUVL)February 28, 2025 | markets.businessinsider.comNuvalent to Participate in Upcoming March Investor ConferencesFebruary 28, 2025 | prnewswire.comNuvalent, Inc. Reports 2024 Financial Results and Pipeline ProgressFebruary 28, 2025 | tipranks.comNuvalent reports Q4 EPS ($1.05), consensus ($1.05)February 27, 2025 | markets.businessinsider.comNuvalent Outlines Pipeline and Business Progress, Reiterates Key Anticipated Milestones, and Reports Fourth Quarter and Full Year 2024 Financial ResultsFebruary 27, 2025 | prnewswire.comAnalysts Offer Insights on Healthcare Companies: Nuvalent (NUVL) and Rhythm Pharmaceuticals (RYTM)February 27, 2025 | markets.businessinsider.comMatthew Shair Sells 2,000 Shares of Nuvalent, Inc. (NASDAQ:NUVL) StockNuvalent, Inc. (NASDAQ:NUVL - Get Free Report) Director Matthew Shair sold 2,000 shares of the business's stock in a transaction that occurred on Monday, February 24th. The shares were sold at an average price of $78.43, for a total transaction of $156,860.00. Following the transaction, the director now directly owns 216,522 shares of the company's stock, valued at $16,981,820.46. The trade was a 0.92 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.February 26, 2025 | marketbeat.comInsider Selling: Nuvalent, Inc. (NASDAQ:NUVL) Director Sells 2,000 Shares of StockFebruary 26, 2025 | insidertrades.comJames Richard Porter Sells 27,000 Shares of Nuvalent, Inc. (NASDAQ:NUVL) StockNuvalent, Inc. (NASDAQ:NUVL - Get Free Report) CEO James Richard Porter sold 27,000 shares of the company's stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $78.46, for a total transaction of $2,118,420.00. Following the completion of the transaction, the chief executive officer now owns 249,062 shares in the company, valued at $19,541,404.52. This trade represents a 9.78 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.February 21, 2025 | marketbeat.comNuvalent (NUVL) Projected to Post Quarterly Earnings on TuesdayNuvalent (NASDAQ:NUVL) will be releasing earnings on Tuesday, February 25, Financial Modeling Prep reports.February 18, 2025 | marketbeat.comWhy Insiders Are Selling Nuvalent, Inc. (NUVL) RecentlyFebruary 11, 2025 | msn.comNuvalent, Inc. (NASDAQ:NUVL) Holdings Lifted by abrdn plcabrdn plc raised its position in Nuvalent, Inc. (NASDAQ:NUVL - Free Report) by 19.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 56,701 shares of the company's stock after purchasing an additional 9,241 shares during thFebruary 10, 2025 | marketbeat.comQ1 Earnings Forecast for Nuvalent Issued By Leerink PartnrsNuvalent, Inc. (NASDAQ:NUVL - Free Report) - Stock analysts at Leerink Partnrs issued their Q1 2025 earnings estimates for Nuvalent in a research report issued on Wednesday, February 5th. Leerink Partnrs analyst A. Berens forecasts that the company will post earnings of ($1.14) per share for theFebruary 10, 2025 | marketbeat.comNuvalent, Inc. (NASDAQ:NUVL) Given Consensus Rating of "Moderate Buy" by AnalystsShares of Nuvalent, Inc. (NASDAQ:NUVL - Get Free Report) have been assigned an average rating of "Moderate Buy" from the fourteen analysts that are presently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, one has given a hold ratingFebruary 10, 2025 | marketbeat.comQ2 Earnings Forecast for Nuvalent Issued By Leerink PartnrsNuvalent, Inc. (NASDAQ:NUVL - Free Report) - Equities research analysts at Leerink Partnrs issued their Q2 2025 EPS estimates for Nuvalent in a report released on Wednesday, February 5th. Leerink Partnrs analyst A. Berens expects that the company will post earnings of ($1.17) per share for the quFebruary 7, 2025 | marketbeat.comNuvalent (NASDAQ:NUVL) Is In A Good Position To Deliver On Growth PlansFebruary 6, 2025 | uk.finance.yahoo.comNuvalent, Inc. (NASDAQ:NUVL) Director Sells $165,580.00 in StockJanuary 30, 2025 | insidertrades.comNuvalent, Inc. (NASDAQ:NUVL) Holdings Boosted by SG Americas Securities LLCSG Americas Securities LLC boosted its holdings in Nuvalent, Inc. (NASDAQ:NUVL - Free Report) by 46.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 10,793 shares of the company's stock after acquiring an additiJanuary 30, 2025 | marketbeat.comNuvalent director Matthew Shair sells shares worth $165,575January 29, 2025 | msn.comNuvalent: A First LookJanuary 22, 2025 | seekingalpha.comIs Nuvalent, Inc. (NUVL) Among Billionaire Joseph Edelman’s Long-Term Stock Picks?January 20, 2025 | msn.comNuvalent, Inc. (NASDAQ:NUVL) CEO Sells $2,051,730.00 in StockJanuary 18, 2025 | insidertrades.comNuvalent stock reiterates buy rating on FDA approval potentialJanuary 17, 2025 | msn.comNuvalent’s Clinical Advancements and Strategic Growth Drive Buy Rating with $110 Price TargetJanuary 17, 2025 | markets.businessinsider.comNuvalent, Inc. (NASDAQ:NUVL) CEO James Richard Porter Sells 27,000 SharesNuvalent, Inc. (NASDAQ:NUVL - Get Free Report) CEO James Richard Porter sold 27,000 shares of the firm's stock in a transaction on Wednesday, January 15th. The stock was sold at an average price of $75.99, for a total value of $2,051,730.00. Following the completion of the sale, the chief executive officer now directly owns 249,062 shares of the company's stock, valued at approximately $18,926,221.38. This trade represents a 9.78 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.January 17, 2025 | marketbeat.comNuvalent (NASDAQ:NUVL) Receives Buy Rating from HC WainwrightHC Wainwright reissued a "buy" rating and issued a $110.00 target price on shares of Nuvalent in a research note on Friday.January 17, 2025 | marketbeat.comNuvalent's SWOT analysis: biotech stock shows promise amid clinical progressJanuary 16, 2025 | msn.comNuvalent, Inc. (NASDAQ:NUVL) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesNuvalent, Inc. (NASDAQ:NUVL - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the fourteen brokerages that are covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendation, elevenJanuary 16, 2025 | marketbeat.comPiper Sandler Sticks to Their Buy Rating for Nuvalent (NUVL)January 15, 2025 | markets.businessinsider.comBarclays Reaffirms Their Buy Rating on Nuvalent (NUVL)January 14, 2025 | markets.businessinsider.com Remove Ads Get Nuvalent News Delivered to You Automatically Sign up to receive the latest news and ratings for NUVL and its competitors with MarketBeat's FREE daily newsletter. Email Address NUVL Media Mentions By Week NUVL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NUVL News Sentiment▼1.210.70▲Average Medical News Sentiment NUVL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NUVL Articles This Week▼105▲NUVL Articles Average Week Remove Ads Get Nuvalent News Delivered to You Automatically Sign up to receive the latest news and ratings for NUVL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TEVA News Today SMMT News Today ITCI News Today GMAB News Today MRNA News Today VTRS News Today RDY News Today ASND News Today SRPT News Today PCVX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NUVL) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuvalent, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuvalent With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
